89 related articles for article (PubMed ID: 14612385)
1. Sodium-dependent methotrexate carrier-1 is expressed in rat kidney: cloning and functional characterization.
Kneuer C; Honscha KU; Honscha W
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F564-71. PubMed ID: 14612385
[TBL] [Abstract][Full Text] [Related]
2. Cloning and functional characterization of the bile acid-sensitive methotrexate carrier from rat liver cells.
Honscha W; Dötsch KU; Thomsen N; Petzinger E
Hepatology; 2000 Jun; 31(6):1296-304. PubMed ID: 10827155
[TBL] [Abstract][Full Text] [Related]
3. Rat reduced-folate carrier-1 is localized basolaterally in MDCK kidney epithelial cells and contributes to the secretory transport of methotrexate and fluoresceinated methotrexate.
Kneuer C; Honscha KU; Honscha W
Cell Tissue Res; 2005 Jun; 320(3):517-24. PubMed ID: 15846510
[TBL] [Abstract][Full Text] [Related]
4. The H(+)-dependent reduced folate carrier 1 of humans and the sodium-dependent methotrexate carrier-1 of the rat are orthologs.
Kneuer C; Honscha W
FEBS Lett; 2004 May; 566(1-3):83-6. PubMed ID: 15147873
[TBL] [Abstract][Full Text] [Related]
5. The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase.
von Dippe P; Amoui M; Stellwagen RH; Levy D
J Biol Chem; 1996 Jul; 271(30):18176-80. PubMed ID: 8663355
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney.
Saito H; Masuda S; Inui Ki
J Biol Chem; 1996 Aug; 271(34):20719-25. PubMed ID: 8702823
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney.
Masuda S; Ibaramoto K; Takeuchi A; Saito H; Hashimoto Y; Inui KI
Mol Pharmacol; 1999 Apr; 55(4):743-52. PubMed ID: 10101033
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the bile acid sensitive methotrexate carrier of rat liver cells.
Honscha W; Petzinger E
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):411-9. PubMed ID: 10498292
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter.
Nakai Y; Inoue K; Abe N; Hatakeyama M; Ohta KY; Otagiri M; Hayashi Y; Yuasa H
J Pharmacol Exp Ther; 2007 Aug; 322(2):469-76. PubMed ID: 17475902
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
Brigle KE; Spinella MJ; Sierra EE; Goldman ID
J Biol Chem; 1995 Sep; 270(39):22974-9. PubMed ID: 7559435
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
[TBL] [Abstract][Full Text] [Related]
14. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells.
Wong SC; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1995 Jul; 270(29):17468-75. PubMed ID: 7615551
[TBL] [Abstract][Full Text] [Related]
15. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Na+-dependent bile salt uptake by WIF-B cells, a rat hepatoma hybrid cell line, following growth in the presence of a physiological bile salt.
Konieczko EM; Ralston AK; Crawford AR; Karpen SJ; Crawford JM
Hepatology; 1998 Jan; 27(1):191-9. PubMed ID: 9425937
[TBL] [Abstract][Full Text] [Related]
17. The antiepileptic drugs phenobarbital and carbamazepine reduce transport of methotrexate in rat choroid plexus by down-regulation of the reduced folate carrier.
Halwachs S; Lakoma C; Schäfer I; Seibel P; Honscha W
Mol Pharmacol; 2011 Oct; 80(4):621-9. PubMed ID: 21737571
[TBL] [Abstract][Full Text] [Related]
18. Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
Biswal BK; Verma RS
J Biochem; 2009 Nov; 146(5):693-703. PubMed ID: 19692428
[TBL] [Abstract][Full Text] [Related]
19. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
Yokooji T; Mori N; Murakami T
J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
[TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
